Rockwell Medical to Release First Quarter 2025 Results on Monday, May 12, 2025

WIXOM, Mich.--(BUSINESS WIRE)--April 14, 2025-- 

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the first quarter ended March 31, 2025 on Monday, May 12, 2025. The Company will issue a press release at 6:00am ET followed by a live conference call and webcast at 8:00am ET.

CONFERENCE CALL AND WEBCAST DETAILS

Date: Monday, May 12, 2025

Time: 8:00am ET

Live Number: (888) 660-6347 // (International) 1 (929) 201-6594

Conference Call ID: 4944610

Webcast and Replay: www.RockwellMed.com/Results

Speakers:

   -- Mark Strobeck, Ph.D. -- President and Chief Executive Officer; and 
 
   -- Jesse Neri -- SVP, Chief Financial Officer 

Format: Discussion of first quarter 2025 financial and operational results followed by Q&A.

About Rockwell Medical

Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is typically performed at freestanding outpatient dialysis centers, hospital-based outpatient centers, skilled nursing facilities, or in a patient's home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Certified as a Great Place to Work$(R)$ in 2023, 2024 and 2025, and named Fortune Best Workplaces in Manufacturing & Production$(TM)$ in 2024, Rockwell Medical is Driven to Deliver Life-Sustaining Dialysis Solutions(TM) . For more information, visit www.rockwellmed.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250414889038/en/

 
    CONTACT:    Heather R. Hunter 

SVP, Chief Corporate Affairs Officer

(248) 432-1362

IR@RockwellMed.com

(END) Dow Jones Newswires

April 14, 2025 06:01 ET (10:01 GMT)